Establishment of the early-life microbiome: a DOHaD perspective

J Dev Orig Health Dis. 2020 Jun;11(3):201-210. doi: 10.1017/S2040174419000588. Epub 2019 Oct 11.

Abstract

The human microbiome plays a number of critical roles in host physiology. Evidence from longitudinal cohort studies and animal models strongly supports the theory that maldevelopment of the microbiome in early life can programme later-life disease. The early-life microbiome develops in a clear stepwise manner over the first 3 years of life. During this highly dynamic time, insults such as antibiotic use and formula feeding can adversely affect the composition and temporal development of the microbiome. Such experiences predispose infants for the development of chronic health conditions later in life. This review highlights key factors that disrupt the early-life microbiome and highlights major non-communicable diseases which are underpinned by early-life dysbiosis.

Keywords: antibiotics; breastfeeding; early-life microbiome; maternal microbiome; non-communicable diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Bottle Feeding / adverse effects*
  • Breast Feeding
  • Child Development / physiology*
  • Dysbiosis / chemically induced
  • Dysbiosis / microbiology
  • Dysbiosis / physiopathology*
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Infant
  • Infant, Newborn

Substances

  • Anti-Bacterial Agents